# Manhattan Bridge Capital, Inc: financial statements, quarterly

LOAN · Nasdaq · CIK 1080340 · [Real estate](/sectors/real-estate.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/loan.md) · [Financials](/companies/loan/financials.md) · [Filings](/companies/loan/filings.md) · [Insiders](/companies/loan/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/loan/financials.md?period=annual).

## Income statement

| Line item | Unit | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $k | [2,565 d](/filings/0001493152-25-009931.md) | [2,573](/filings/0001641172-25-005931.md) | [2,443](/filings/0001493152-25-011328.md) | [2,313](/filings/0001493152-25-019314.md) | [2,359 d](/filings/0001493152-26-013241.md) | [2,274](/filings/0001493152-26-016965.md) | [2,355](/filings/0001493152-26-034411.md) | [2,036](/filings/0001493152-26-047912.md) | [2,002 d](/filings/0001493152-26-013241.md) | [2,068](/filings/0001493152-26-016965.md) | [2,045](/filings/0001493152-26-034411.md) | [2,054](/filings/0001493152-26-047912.md) |
| Operating income | $k | [1,344 d](/filings/0001493152-25-009931.md) | [1,472](/filings/0001641172-25-005931.md) | [1,405](/filings/0001493152-25-011328.md) | [1,395](/filings/0001493152-25-019314.md) | [1,302 d](/filings/0001493152-26-013241.md) | [1,369](/filings/0001493152-26-016965.md) | [1,410](/filings/0001493152-26-034411.md) | [1,198](/filings/0001493152-26-047912.md) | [1,118 d](/filings/0001493152-26-013241.md) | [1,270](/filings/0001493152-26-016965.md) | [1,149](/filings/0001493152-26-034411.md) | [1,234](/filings/0001493152-26-047912.md) |
| Interest expense | $k | not reported | [669](/filings/0001641172-25-005931.md) | [581](/filings/0001493152-25-011328.md) | [515](/filings/0001493152-25-019314.md) | [484 d](/filings/0001493152-26-013241.md) | [429](/filings/0001493152-26-016965.md) | [484](/filings/0001493152-26-034411.md) | [400](/filings/0001493152-26-047912.md) | [330 d](/filings/0001493152-26-013241.md) | [345](/filings/0001493152-26-016965.md) | [380](/filings/0001493152-26-034411.md) | [351](/filings/0001493152-26-047912.md) |
| Income tax | $k | [0.0 d](/filings/0001493152-25-009931.md) | not reported | [0.7](/filings/0001493152-25-011328.md) | [0.0 d](/filings/0001493152-25-019314.md) | [0.0 d](/filings/0001493152-26-013241.md) | not reported | [1.2](/filings/0001493152-26-034411.md) | [0.0 d](/filings/0001493152-26-047912.md) | [0.0 d](/filings/0001493152-26-013241.md) | not reported | [1.3](/filings/0001493152-26-034411.md) | [0.0 d](/filings/0001493152-26-047912.md) |
| Net income | $k | [1,349 d](/filings/0001493152-25-009931.md) | [1,476](/filings/0001641172-25-005931.md) | [1,409](/filings/0001493152-25-011328.md) | [1,399](/filings/0001493152-25-019314.md) | [1,306 d](/filings/0001493152-26-013241.md) | [1,373](/filings/0001493152-26-016965.md) | [1,413](/filings/0001493152-26-034411.md) | [1,202](/filings/0001493152-26-047912.md) | [1,123 d](/filings/0001493152-26-013241.md) | [1,274](/filings/0001493152-26-016965.md) | [1,153](/filings/0001493152-26-034411.md) | [1,238](/filings/0001493152-26-047912.md) |
| Diluted EPS | $ per share | not reported | [0.13](/filings/0001641172-25-005931.md) | [0.12](/filings/0001493152-25-011328.md) | [0.12](/filings/0001493152-25-019314.md) | not reported | [0.12](/filings/0001493152-26-016965.md) | [0.12](/filings/0001493152-26-034411.md) | [0.11](/filings/0001493152-26-047912.md) | not reported | [0.11](/filings/0001493152-26-016965.md) | [0.10](/filings/0001493152-26-034411.md) | [0.11](/filings/0001493152-26-047912.md) |
| Basic EPS | $ per share | not reported | [0.13](/filings/0001641172-25-005931.md) | [0.12](/filings/0001493152-25-011328.md) | [0.12](/filings/0001493152-25-019314.md) | not reported | [0.12](/filings/0001493152-26-016965.md) | [0.12](/filings/0001493152-26-034411.md) | [0.11](/filings/0001493152-26-047912.md) | not reported | [0.11](/filings/0001493152-26-016965.md) | [0.10](/filings/0001493152-26-034411.md) | [0.11](/filings/0001493152-26-047912.md) |

- Revenue: us-gaap:Revenues
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [0.1](/filings/0001493152-25-009931.md) | [0.1](/filings/0001493152-24-015643.md) | [0.1](/filings/0001493152-24-028628.md) | [0.2](/filings/0001493152-24-042160.md) | [0.2](/filings/0001493152-26-013241.md) | [0.2](/filings/0001641172-25-005931.md) | [0.2](/filings/0001493152-25-011328.md) | [0.2](/filings/0001493152-25-019314.md) | [0.2](/filings/0001493152-26-047912.md) | [0.2](/filings/0001493152-26-016965.md) | [0.2](/filings/0001493152-26-034411.md) | [0.2](/filings/0001493152-26-047912.md) |
| Current assets | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Total assets | $m | [76.4](/filings/0001493152-25-009931.md) | [74.8](/filings/0001493152-24-015643.md) | [68.8](/filings/0001493152-24-028628.md) | [70.7](/filings/0001493152-24-042160.md) | [67.4](/filings/0001493152-26-013241.md) | [65.8](/filings/0001641172-25-005931.md) | [67.6](/filings/0001493152-25-011328.md) | [60.0](/filings/0001493152-25-019314.md) | [62.4](/filings/0001493152-26-047912.md) | [64.3](/filings/0001493152-26-016965.md) | [64.0](/filings/0001493152-26-034411.md) | [61.5](/filings/0001493152-26-047912.md) |
| Current liabilities | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Total liabilities | $m | [33.5](/filings/0001493152-25-009931.md) | [31.7](/filings/0001493152-24-015643.md) | [25.6](/filings/0001493152-24-028628.md) | [27.4](/filings/0001493152-24-042160.md) | [24.1](/filings/0001493152-26-013241.md) | [22.5](/filings/0001641172-25-005931.md) | [24.2](/filings/0001493152-25-011328.md) | [16.7](/filings/0001493152-25-019314.md) | [19.3](/filings/0001493152-26-047912.md) | [21.1](/filings/0001493152-26-016965.md) | [21.0](/filings/0001493152-26-034411.md) | [18.7](/filings/0001493152-26-047912.md) |
| Long-term debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Short-term borrowings | $m | not reported | not reported | not reported | not reported | [7.2](/filings/0001493152-26-013241.md) | [7.7](/filings/0001641172-25-005931.md) | [7.9](/filings/0001493152-25-011328.md) | [6.2](/filings/0001493152-25-019314.md) | [6.2](/filings/0001493152-26-013241.md) | [6.2](/filings/0001493152-26-016965.md) | not reported | not reported |
| Shareholders' equity | $m | [42.9](/filings/0001493152-26-013241.md) | [43.1](/filings/0001493152-25-011328.md) | [43.2](/filings/0001493152-25-019314.md) | [43.3](/filings/0001493152-25-019314.md) | [43.3](/filings/0001493152-26-047912.md) | [43.3](/filings/0001493152-26-034411.md) | [43.4](/filings/0001493152-26-047912.md) | [43.3](/filings/0001493152-26-047912.md) | [43.1](/filings/0001493152-26-047912.md) | [43.1](/filings/0001493152-26-034411.md) | [43.0](/filings/0001493152-26-047912.md) | [42.8](/filings/0001493152-26-047912.md) |

- Cash and equivalents: us-gaap:Cash
- Current assets: not reported
- Total assets: us-gaap:Assets
- Current liabilities: not reported
- Total liabilities: us-gaap:Liabilities
- Long-term debt: not reported
- Short-term borrowings: us-gaap:ShortTermBorrowings
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $k | [1,258 d](/filings/0001493152-25-009931.md) | [1,141](/filings/0001641172-25-005931.md) | [1,285 d](/filings/0001493152-25-011328.md) | [1,236 d](/filings/0001493152-25-019314.md) | [1,271 d](/filings/0001493152-26-013241.md) | [1,181](/filings/0001493152-26-016965.md) | [1,226 d](/filings/0001493152-26-034411.md) | [1,399 d](/filings/0001493152-26-047912.md) | [1,123 d](/filings/0001493152-26-013241.md) | [1,259](/filings/0001493152-26-016965.md) | [1,433 d](/filings/0001493152-26-034411.md) | [1,335 d](/filings/0001493152-26-047912.md) |
| Capital expenditure | $k | [0.0 d](/filings/0001493152-25-009931.md) | not reported | not reported | [2.8 d](/filings/0001493152-25-019314.md) | [0.0 d](/filings/0001493152-26-013241.md) | not reported | not reported | [0.0 d](/filings/0001493152-26-047912.md) | [0.0 d](/filings/0001493152-26-013241.md) | not reported | not reported | not reported |
| Dividends paid | $k | [1,289 d](/filings/0001493152-25-009931.md) | [1,287](/filings/0001641172-25-005931.md) | [1,315 d](/filings/0001493152-25-011328.md) | [1,315 d](/filings/0001493152-25-019314.md) | [1,315 d](/filings/0001493152-26-013241.md) | [1,315](/filings/0001493152-26-016965.md) | [1,315 d](/filings/0001493152-26-034411.md) | [1,315 d](/filings/0001493152-26-047912.md) | [1,315 d](/filings/0001493152-26-013241.md) | [1,315](/filings/0001493152-26-016965.md) | [1,257 d](/filings/0001493152-26-034411.md) | [1,257 d](/filings/0001493152-26-047912.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividends

## Shares

| Line item | Unit | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [11.5](/filings/0001493152-24-015643.md) | [11.5](/filings/0001493152-24-028628.md) | [11.5](/filings/0001493152-24-042160.md) | [11.4](/filings/0001641172-25-005931.md) | [11.4](/filings/0001493152-25-011328.md) | [11.4](/filings/0001493152-25-019314.md) | [11.4](/filings/0001493152-26-016965.md) | [11.4](/filings/0001493152-26-034411.md) | [11.4](/filings/0001493152-26-047912.md) | [11.4](/filings/0001493152-26-016965.md) | [11.4](/filings/0001493152-26-034411.md) | [11.4](/filings/0001493152-26-047912.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 11,347,523 at 2026-10-21, from the cover of the [10-Q filed 2026-10-21](/filings/0001493152-26-047912.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:32 ET. No prices; not investment advice.